TTI-622-01: A phase 1a/1b dose-escalation and expansion trial of TTI-622 in patients with advanced hematologic malignancies, including multiple myeloma Meeting Abstract
| Authors: | Patel, K.; Orlowski, R. Z.; Doucette, K.; Maris, M.; Pianko, M. J.; Ramchandren, R.; Stevens, D. A.; Vesole, D. H.; Uger, R. A.; Scheuber, A.; Molloy, N.; Bruns, I.; Lesokhin, A. M. |
| Abstract Title: | TTI-622-01: A phase 1a/1b dose-escalation and expansion trial of TTI-622 in patients with advanced hematologic malignancies, including multiple myeloma |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680305099 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.TPS8071 |
| Notes: | Meeting Abstract: TPS8071 -- Meeting also held virtually -- Source: Wos |
